195 related articles for article (PubMed ID: 18425592)
21. Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul study.
Otte C; Wüst S; Zhao S; Pawlikowska L; Kwok PY; Whooley MA
J Clin Endocrinol Metab; 2010 Jun; 95(6):2885-91. PubMed ID: 20371666
[TBL] [Abstract][Full Text] [Related]
22. Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration.
Han X; Ong JS; An J; Hewitt AW; Gharahkhani P; MacGregor S
Eur J Epidemiol; 2020 Feb; 35(2):139-146. PubMed ID: 31900758
[TBL] [Abstract][Full Text] [Related]
23. C-reactive Protein Level, Apolipoprotein B-to-apolipoprotein A-1 Ratio, and Risks of Ischemic Stroke and Coronary Heart Disease among Inner Mongolians in China.
Tian YF; Zhou YP; Zhong CK; Buren B; Xu T; Li HM; Zhang MZ; Wang AL; Zhang YH
Biomed Environ Sci; 2016 Jul; 29(7):467-74. PubMed ID: 27554116
[TBL] [Abstract][Full Text] [Related]
24. Variants in the CRP gene as a measure of lifelong differences in average C-reactive protein levels: the Cardiovascular Risk in Young Finns Study, 1980-2001.
Kivimäki M; Lawlor DA; Smith GD; Eklund C; Hurme M; Lehtimäki T; Viikari JS; Raitakari OT
Am J Epidemiol; 2007 Oct; 166(7):760-4. PubMed ID: 17641153
[TBL] [Abstract][Full Text] [Related]
25. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.
Danesh J; Collins R; Appleby P; Peto R
JAMA; 1998 May; 279(18):1477-82. PubMed ID: 9600484
[TBL] [Abstract][Full Text] [Related]
26. Sleep duration, C-reactive protein and risk of incident coronary heart disease--results from the Framingham Offspring Study.
Liu J; Yuen J; Kang S
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):600-5. PubMed ID: 24548663
[TBL] [Abstract][Full Text] [Related]
27. Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study.
Kivimäki M; Lawlor DA; Smith GD; Kumari M; Donald A; Britton A; Casas JP; Shah T; Brunner E; Timpson NJ; Halcox JP; Miller MA; Humphries SE; Deanfield J; Marmot MG; Hingorani AD
PLoS One; 2008 Aug; 3(8):e3013. PubMed ID: 18714381
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.
Buckley DI; Fu R; Freeman M; Rogers K; Helfand M
Ann Intern Med; 2009 Oct; 151(7):483-95. PubMed ID: 19805771
[TBL] [Abstract][Full Text] [Related]
29. ANRIL polymorphisms (rs1333049 and rs3217992) in relation to plasma CRP levels among in-patients with CHD.
Reichert S; Seitter L; Schaller HG; Schlitt A; Schulz S
Cytokine; 2020 Mar; 127():154932. PubMed ID: 31770616
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein.
Halder I; Marsland AL; Cheong J; Muldoon MF; Ferrell RE; Manuck SB
Brain Behav Immun; 2010 Jan; 24(1):160-7. PubMed ID: 19796676
[TBL] [Abstract][Full Text] [Related]
31. Systemic inflammation, genetic susceptibility and lung function.
Sunyer J; Pistelli R; Plana E; Andreani M; Baldari F; Kolz M; Koenig W; Pekkanen J; Peters A; Forastiere F
Eur Respir J; 2008 Jul; 32(1):92-7. PubMed ID: 18385179
[TBL] [Abstract][Full Text] [Related]
32. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality.
Davey Smith G; Lawlor DA; Harbord R; Timpson N; Rumley A; Lowe GD; Day IN; Ebrahim S
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1051-6. PubMed ID: 15731495
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
[TBL] [Abstract][Full Text] [Related]
34. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.
Yanbaeva DG; Dentener MA; Spruit MA; Houwing-Duistermaat JJ; Kotz D; Passos VL; Wouters EF
BMC Med Genet; 2009 Mar; 10():23. PubMed ID: 19272152
[TBL] [Abstract][Full Text] [Related]
35. CRP and SAA1 Haplotypes Are Associated with Both C-Reactive Protein and Serum Amyloid A Levels: Role of Suppression Effects.
Ko YL; Hsu LA; Wu S; Teng MS; Chou HH
Mediators Inflamm; 2016; 2016():5830361. PubMed ID: 27313400
[TBL] [Abstract][Full Text] [Related]
36. The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study.
Bolton CE; Schumacher W; Cockcroft JR; Timpson NJ; Smith GD; Gallacher J; Rumley A; Lowe GD; Ebrahim S; Shale DJ; Ben-Shlomo Y
Clin Sci (Lond); 2011 Apr; 120(8):347-55. PubMed ID: 21080913
[TBL] [Abstract][Full Text] [Related]
37. Association of Coronary Heart Disease and CRP - as a Noble Marker of Inflammation - A Case Control Study.
Sarkar NC; Sarkar P; Sarkar P; Das S
J Assoc Physicians India; 2019 Oct; 67(10):54-56. PubMed ID: 31571453
[TBL] [Abstract][Full Text] [Related]
38. Exploring the effects of C-reactive protein (CRP) and interleukin-1 beta single nucleotide polymorphisms on CRP concentration in patients with established coronary artery disease. Classification tree approach.
Lin JW; Dai DF; Chou YH; Huang LY; Hwang JJ
Int Heart J; 2007 Jul; 48(4):463-75. PubMed ID: 17827818
[TBL] [Abstract][Full Text] [Related]
39. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress.
Martin NJ; Collier AC; Bowen LD; Pritsos KL; Goodrich GG; Arger K; Cutter G; Pritsos CA
Mutat Res; 2009 Mar; 674(1-2):93-100. PubMed ID: 18950733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
